ALFA Finder| Revenue growth | Revenue +19.4% YoY to ₹87.1 Cr; H1 ₹170 Cr. |
|---|---|
| Margins | EBITDA margin 8.31% vs 8.01%; gross margin ~6 pts lower YoY. |
| Demand visibility | Returning-customer cohort growth 27%; management unsure of next-quarter revenue. |
| Management confidence | Balanced-to-optimistic; admits missed sales, defends stockouts and inventory build. |
Growth
Revenue +19.4% YoY; EBITDA +23.9%. Opex fell to 18.9% of revenue from 25.2%; gross margin nearly 6 pts lower.
Outlook
No quantified FY27 guidance. Long-term: EBITDA margin 13–18% 'over time'; opex 12% of revenue benchmark.
Risks
Inventory ₹104 Cr vs ~₹40 Cr cash; ₹10 Cr equipment sales missed; orders/customer down to 2.66; delivery ~4 days.
Earnings Call Transcript filed with NSE, NSE: DENTALKART. Summary written with AI assistance from the document.
Vasa Denticity Ltd: key numbers
- Share price
- ₹459.60
- Market cap
- ₹763.9 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹10.24 Cr
- P/E (TTM)
- 74.6×Sector 54.4×
- Promoter holding
- 59.65%-0.54% QoQ
- FII holding
- 7.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vasa Denticity Ltd
All →Vasa Denticity Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹87.10 Cr (+19.4% YoY), PAT ₹5.20 Cr (+8.8%), Op. EBITDA ₹7.24 Cr (+23.9%, 8.3% margin). Margin recovery driven by lower operating costs, not gross margin.
Vasa Denticity Management Change
Vasa Denticity re-appointed Independent Director Varun Chugh for five years, effective November 6, 2026. Shareholder approval at a general meeting is pending.
- Execution
- November 6, 2026 to November 6, 2031
Vasa Denticity Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 8.3% YoY
Vasa Denticity Ltd reported revenue from operations of ₹87.1 Cr (+19.5% YoY) and net profit of ₹5.2 Cr (+8.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +8.3% YoY
Vasa Denticity Board Meeting Date
VASA Denticity Limited will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.
Vasa Denticity Convertible Warrants
Vasa Denticity received NSE trading approval for 1,50,000 shares from preferential warrant conversion. Listed capital rises to ₹17.49 crore, with trading from 02 November 2026.
Vasa Denticity Other Announcement
Vasa Denticity Limited informed that the Corporate Governance Report is not applicable to the company as it is listed on the SME platform.